Isoniazid Derivatives as Anti-Tubercular Agents: From Structural Design to Clinical Investigations.

Ridahunlang, Nongkhlaw; Bisht, Rohit; Rishanlang, Nongkhlaw

Ridahunlang, Nongkhlaw; Bisht, Rohit; Rishanlang, Nongkhlaw.

Afiliación

Ridahunlang N; Department of Chemistry, North Eastern Hill University, Shillong, India.
Bisht R; Department of Pharmaceutical Research, Research Communication Lab, Haldwani, Uttarakhand, India.
Rishanlang N; Department of Chemistry, North Eastern Hill University, Shillong, India.

Infect Disord Drug Targets ; 23(3): e041022209552, 2023.

Article en En | MEDLINE | ID: mdl-36200205

Asunto(s)

Mycobacterium tuberculosis; Tuberculosis; Humanos; Isoniazida/farmacología; Antituberculosos/uso terapéutico; Tuberculosis/tratamiento farmacológico; Tuberculosis/microbiología; Modelos Moleculares

Palabras clave

Anti-TB agents; Mycobacterium tuberculosis (Mtb); anti-tubercular activity; isoniazid; isoniazid derivatives; multi-drug resistance; toxicity

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Tuberculosis / Mycobacterium tuberculosis Límite: Humans Idioma: En Revista: Infect Disord Drug Targets Asunto de la revista: DOENCAS TRANSMISSIVEIS / TERAPIA POR MEDICAMENTOS Año: 2023 Tipo del documento: Article País de afiliación: India

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google